CEL-SCI Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.72M and sold 0 CVM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 3.72M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
May 08, 2024
Buy
Common Stock
P-Purchase
Watson Robert Eugene
Director
Director 20 000
Value: $27.8K
May 08, 2024
Buy
Common Stock
P-Purchase
Watson Robert Eugene
Director
Director 20 000
Value: $27.8K
May 08, 2024
Buy
Common Stock
P-Purchase
Prichep Patricia B
Senior Vice President
CEO / President 8 000
Value: $11.1K
May 08, 2024
Buy
Common Stock
P-Purchase
Kersten Geert R
Chief Executive Officer
CEO / President 30 000
Value: $41.7K
May 08, 2024
Buy
Common Stock
P-Purchase
Kersten Geert R
Chief Executive Officer
CEO / President 30 000
Value: $41.7K
May 08, 2024
Buy
Common Stock
P-Purchase
Prichep Patricia B
Senior Vice President
CEO / President 8 000
Value: $11.1K
Apr 19, 2024
Buy
Common Stock
Gobbo Mario
Director
Director 0
Value: $0
Apr 19, 2024
Buy
Options
Gobbo Mario
Director
Director 64 000
Value: $96.0K
Apr 19, 2024
Buy
Options
A-Award
Watson Robert Eugene
Director
Director 64 000
Value: $96.0K
Apr 19, 2024
Buy
Options
A-Award
Baillavoine Bruno Jean-marie
Director
Director 64 000
Value: $96.0K
Apr 19, 2024
Buy
Options
A-Award
Talor Eyal
Chief Scientific Officer
Officer 182 000
Value: $273.0K
Apr 19, 2024
Buy
Options
A-Award
Prichep Patricia B
Senior Vice President
CEO / President 167 000
Value: $250.5K
Apr 19, 2024
Buy
Options
A-Award
Kersten Geert R
Chief Executive Officer
CEO / President 250 000
Value: $375.0K
Apr 19, 2024
Buy
Options
A-Award
Kersten Geert R
Chief Executive Officer
CEO / President 250 000
Value: $375.0K
Apr 19, 2024
Buy
Options
A-Award
Prichep Patricia B
Senior Vice President
CEO / President 167 000
Value: $250.5K
Apr 19, 2024
Buy
Options
A-Award
Talor Eyal
Chief Scientific Officer
Officer 182 000
Value: $273.0K
Apr 19, 2024
Buy
Options
A-Award
Baillavoine Bruno Jean-marie
Director
Director 64 000
Value: $96.0K
Apr 19, 2024
Buy
Options
A-Award
Watson Robert Eugene
Director
Director 64 000
Value: $96.0K
Apr 19, 2024
Buy
Options
Gobbo Mario
Director
Director 64 000
Value: $96.0K
Apr 19, 2024
Buy
Common Stock
Gobbo Mario
Director
Director 0
Value: $0
Mar 29, 2024
Buy
Common Stock
A-Award
Talor Eyal
Chief Scientific Officer
Officer 1 256
Value: $2K
Mar 29, 2024
Buy
Common Stock
A-Award
Prichep Patricia B
Senior Vice President
CEO / President 2 246
Value: $4K
Mar 29, 2024
Buy
Common Stock
A-Award
Kersten Geert R
Chief Executive Officer
CEO / President 2 709
Value: $5K
Mar 29, 2024
Buy
Common Stock
A-Award
Prichep Patricia B
Senior Vice President
CEO / President 2 246
Value: $4K
Mar 29, 2024
Buy
Common Stock
A-Award
Talor Eyal
Chief Scientific Officer
Officer 1 256
Value: $2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CEL-SCI CORPORATION
CEL-SCI
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE